Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain

We analyzed the effect of COVID-19 on healthcare demand and invasive pneumococcal disease in children in Catalonia, Spain. Compared with 2018-2019, we noted large reductions in healthcare activities and incidence of invasive pneumococcal disease in 2020. These changes likely resulted from nonpharmac...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Emerging infectious diseases 2022-11, Vol.28 (11), p.2321-2325
Hauptverfasser:	Ciruela, Pilar, Soldevila, Núria, García-Garcia, Juan José, González-Peris, Sebastià, Díaz-Conradi, Alvaro, Redin, Alba, Viñado, Belén, Izquierdo, Conchita, Muñoz-Almagro, Carmen, Domínguez, Angela
Format:	Artikel
Sprache:	eng
Schlagworte:	13-valent pneumococcal conjugate vaccine Age Child Communicable diseases in children Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 vaccines Disease transmission Dispatch Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain Emergency medical care Epidemics Epidemiology Health care Hospitals Humans Incidence Infant Influence Influenza invasive pneumococcal disease Medical care nonpharmaceutical measures Pandemics Patient admissions Pediatric research Pediatrics Pneumococcal infections Pneumococcal Infections - epidemiology Pneumococcal Infections - prevention & control Pneumococcal Vaccines Public health Risk factors SARS-CoV-2 serotype Severe acute respiratory syndrome coronavirus 2 Social distancing Social research Spain Spain - epidemiology Statistics Streptococcus infections Streptococcus pneumoniae Utilization Vaccines, Conjugate Viral infections
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We analyzed the effect of COVID-19 on healthcare demand and invasive pneumococcal disease in children in Catalonia, Spain. Compared with 2018-2019, we noted large reductions in healthcare activities and incidence of invasive pneumococcal disease in 2020. These changes likely resulted from nonpharmaceutical measures implemented during the COVID-19 pandemic.
ISSN:	1080-6040 1080-6059
DOI:	10.3201/eid2811.211741